C Meneghetti
Impact in
- Biotechnology top 5%
- Transgenic Plants and Applications
- Immunology top 10%
- Toxin Mechanisms and Immunotoxins
- T-cell and Retrovirus Studies
Papers in
-
- Toxin Mechanisms and Immunotoxins 7
- Oncology 5
- CAR-T cell therapy research 2
- Co-authors
- CF LeMaistre (5 shared papers)K Parker (4 shared papers)Thasia Woodworth (4 shared papers)Michael G. Rosenblum (3 shared papers)A. B. Deisseroth (3 shared papers)James M. Reuben (3 shared papers)James O. Shaw (2 shared papers)C. Frederick LeMaistre (3 shared papers)
- Journals
- Blood (4 papers)The Lancet (1 paper)American Journal of Hematology (1 paper)European Journal Of Haematology (1 paper)Breast Cancer Research and Treatment (1 paper)
- Partner nations
- United StatesCanada
In The Last Decade
C Meneghetti
10 papers receiving 506 citations
Peers
Comparison fields: 5 of 53
- Biotechnology 187
- Immunology 382
- Dermatology 97
- Pathology and Forensic Medicine 85
- Hematology 52
Countries citing papers authored by C Meneghetti
This map shows the geographic impact of C Meneghetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Meneghetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Meneghetti more than expected).
Fields of papers citing papers by C Meneghetti
This network shows the impact of papers produced by C Meneghetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Meneghetti. The network helps show where C Meneghetti may publish in the future.
Co-authors
The 25 scholars most cited alongside C Meneghetti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 134 | |
| 2 | 1992 | 104 | |
| 3 | 1991 | 93 | |
| 4 | Phase I trial of a 90-minute infusion of the fusion toxin DAB486IL-2 in hematological cancers. | 1993 | 70 |
| 5 | 1994 | 36 | |
| 6 | 1991 | 29 | |
| 7 | 1991 | 20 | |
| 8 | 1992 | 19 | |
| 9 | Methylprednisolone, cyclosporine and methotrexate for prophylaxis of acute graft-versus-host disease. | 1990 | 16 |
| 10 | 1991 | 7 |
About C Meneghetti
C Meneghetti is a scholar working on Immunology, Oncology, Biotechnology, Hematology and Pathology and Forensic Medicine, having authored 10 papers that have together received 528 indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (7 papers), Transgenic Plants and Applications (5 papers), Hematopoietic Stem Cell Transplantation (3 papers), CAR-T cell therapy research (2 papers), Cutaneous lymphoproliferative disorders research (2 papers), Lymphoma Diagnosis and Treatment (1 paper), Cytomegalovirus and herpesvirus research (1 paper) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Biotechnology (187 citations), Immunology (382 citations), Dermatology (97 citations), Pathology and Forensic Medicine (85 citations) and Hematology (52 citations). C Meneghetti has collaborated with scholars based in United States and Canada. Frequent co-authors include CF LeMaistre, K Parker, Thasia Woodworth, Michael G. Rosenblum, A. B. Deisseroth, James M. Reuben, James O. Shaw, C. Frederick LeMaistre, A Frankel and Steven T. Rosen. Their work appears in journals such as Blood, The Lancet, American Journal of Hematology, European Journal Of Haematology and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.